DSM Venturing

DSM Venturing, the corporate venture arm of DSM, focuses on investing in innovative startups that align with its mission of improving health, nutrition, and bioscience. Since its inception in 2001, DSM Venturing has invested in over 100 startups across these sectors. Their portfolio includes companies such as NutriLeads, which develops food ingredients with health benefits, and Deep Branch Biotechnology, which converts carbon dioxide into sustainable animal nutrition products. Geographically, DSM Venturing is particularly active in North America and Europe. They typically invest between €1 million and €20 million over the lifetime of a venture, starting with initial investments ranging from €100k to €5 million. They take minority ownership stakes and often lead investment rounds while actively participating in the board activities of their portfolio companies​. DSM Venturing's investment strategy focuses on startups that offer transformative solutions in health, nutrition, and care, as well as animal nutrition and health, and food innovation. They aim to support these companies not only with funding but also with access to DSM's extensive scientific and commercial resources, fostering innovations that have the potential to make significant societal impacts​.